Greece is expected to receive 2,000 doses of monoclonal antibodies on Tuesday, which will be delivered to the Institute for Pharmaceutical Research and Technology. Greece participates in the EU special treatment program.
Monoclonal antibodies will be offered to patients in public hospitals based on specific medical criteria that the infectious disease committee is currently reviewing. This drug should not be used on all COVID-19 patients.
Intravenous treatment should be carried out in hospitals under the supervision of a physician. The purpose of specific therapy is to prevent an exacerbation of the disease.
Monoclonal antibodies are proteins produced in a laboratory that mimic the ability of the immune system to fight coronavirus.
Also, procedures are underway for the procurement of antiviral pills developed by Merck… However, scientists have warned that the availability of good and effective treatments does not eliminate the need for vaccinations.